A phase II trial of imatinib in patients with refractory/relapsed myeloma.
Dispenzieri A, Gertz MA, Lacy MQ, Geyer SM, Greipp PR, Rajkumar SV, Kimlinger T, Lust JA, Fonseca R, Allred J, Witzig TE.
Dispenzieri A, et al. Among authors: greipp pr.
Leuk Lymphoma. 2006 Jan;47(1):39-42. doi: 10.1080/10428190500271269.
Leuk Lymphoma. 2006.
PMID: 16321825
Clinical Trial.